医学
乳突炎
铜绿假单胞菌
免疫抑制
噬菌体疗法
抗生素
头痛
外科
噬菌体
内科学
微生物学
遗传学
大肠杆菌
生物
基因
中耳炎
生物化学
化学
细菌
作者
Julia A. Casazza,Donald Tan,Mark Newcomer,Hitomi Sakano,Brandon Isaacson,Jacob B. Hunter
标识
DOI:10.1097/mao.0000000000004417
摘要
Objective To provide the first description of intratympanic bacteriophage therapy for chronic mastoiditis from multidrug-resistant Pseudomonas aeruginosa in the United States. Patients A 47-year-old woman with chronic mastoiditis in the setting of ciliary dysfunction from cystic fibrosis and immunosuppression from lung transplantation. Interventions Ten concurrent parenteral and intratympanic doses of two custom phages targeting P. aeruginosa followed by IV antibiotic therapy. Main Outcome Measures Resolution of infection confirmed by symptomatology, cultures, and imaging. Results At 5 months after phage treatment, the patient reported resolution of otorrhea, headaches, and hearing impairment. Subsequent cultures showed no growth. Conclusions Bacteriophages can enhance antibiotic activity in cases of drug-resistant chronic mastoiditis.
科研通智能强力驱动
Strongly Powered by AbleSci AI